| NCT Number | NCT07222618 |
| Lead Sponsor | University of California, San Francisco
Collaborators: Genentech, Inc. |
| Conditions | Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS) Primary Progressive, MS (Multiple Sclerosis), MS, Multiple Sclerosis (MS) Secondary Progressive |
| Enrollment | 300 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2028-10-01 (estimated) |
| Study Completion | 2028-10-01 (estimated) |
| Updated on ClinicalTrials.gov | 2025-10-31 |